Full List Of Stories
FTSE 250 movers: Kier climbs, Acacia falls
London's FTSE 250 index was up 0. 19% at 19,895. 34 in afternoon trade on Monday, with Kier Group leading the index higher.
SimiGon revenue increase dampened by order book reduction
SimiGon on Monday posted a double-digit increase in annual revenue, though the company saw $6m wiped off of its backlog order book due to a dispute with a customer.
Asia report: Markets mixed ahead of US-China negotiations
Asian Markets were mixed on Monday with traders in the region closely monitoring the mood ahead of the start of the next round of trade discussions between the US and China, which could prove decisive and bring a protracted period of trade conflict to an end.
Mirada's revenue trounces expectations as Mexican project drives growth
Digital TV software solutions provider Mirada on Monday reported that annual revenues are expected to beat its expectations, aiding a swing back to positive earnings.
Brexit to slow economic growth further in 2019, says report
The UK's economy will slow in the second half of the year as the impact of Brexit uncertainty weighs on growth, according to a leading economic forecaster.
Occupancy growth boosts Lok'n Store's revenue
Lok'n Store Group on Monday reported double-digit interim profit and revenue growth following growth to unit occupancy.
Marlowe's revenues propelled by eight acquisitions
Marlowe on Monday reported "good progress" as it said its annual profits and revenues had both enjoyed significant growth in a year in which the business completed eight acquisitions.
EU endorses wider use of AstraZeneca cancer drug
AstraZeneca's ovarian cancer drug Lynparza on Monday received an endorsement from the European Medicines Agency, where a committee approved it to be used as a first-line maintenance treatment.